Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CMPS compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name
CMPS
COMPASS Pathways plc
Change
Mkt cap
Revenue
Revenue
TARS
Tarsus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CMPS
COMPASS Pathways plc
vs
TARS
Tarsus Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CMPS, solid
TARS, dashed
Supply-chain overlap
Revenue flow
CMPS: latest quarter not drawable. TARS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CMPS
0
None
Shared
0
No disclosed counterparties: CMPS.
Only TARS
6
ELAN
Elanco Tiergesundheit
supplier
—
Elanco
unlisted
supplier
—
LianBio Ophthalmology
unlisted
customer
—
Xi An Grand Chang An Pharmaceutical
unlisted
customer
2 more · TARS chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CMPS
COMPASS Pathways plc
Change
11.57
▼
−5.09%
· post 11.62
Mkt cap
$1.6B
Revenue
—
Revenue
—
TARS
Tarsus Pharmaceuticals, Inc.
Change
74.85
▲
+0.88%
· post 75.94
Closed
Oct 30 '26
Mkt cap
$3.3B
Revenue
$174M
Q2 FY26
Revenue
$451M
FY25
vs
Compare
Closed
Oct 30 '26
CMPS
COMPASS Pathways plc
vs
TARS
Tarsus Pharmaceuticals, Inc.
11.57
▼
−5.09%
post 11.62
Price
74.85
▲
+0.88%
post 75.94
$1.6B
Mkt cap
$3.3B
—
Revenue
$174M
Q2 FY26
—
Revenue
$451M
FY25
Change
Change
CMPS
11.57
▼
−5.09%
vs
TARS
74.85
▲
+0.88%
Closed
Oct 30 '26